Biodesix, Inc. (BDSX) Reports Q3 Loss, Misses Revenue Estimates

Biodesix, Inc. (BDSX) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of$ 0.08. This compares to loss of $0.12 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 12.50%. A quarter ago, it was expected that this company would post a loss of$ 0.09 per share when it actually produced a loss of $0.08, delivering a surprise of 11.11%.Over the last four quarters, the company has surpassed ...